Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma

Published:2016-03-01 Issue:16 Volume:7 Page:21753-21762
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Yao-Yao¹,Zhu Gui-Qi²³,Wang Yue¹,Zheng Ji-Na²³,Ruan Lu-Yi²³,Cheng Zhang²³,Hu Bin²³,Fu Shen-Wen¹,Zheng Ming-Hua²⁴

Affiliation:

1. Department of Cardiology, Jinhua Municipal Hospital, Jinhua 321004, China

2. Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

3. School of The First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou 325000, China

4. Institute of Hepatology, Wenzhou Medical University, Wenzhou 325000, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib;Cancers;2024-01-05

2. Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells via Abating HIF-1α-Wnt/β-Catenin Signaling Pathway;Anti-Cancer Agents in Medicinal Chemistry;2023-11

3. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy;International Journal of Molecular Sciences;2023-02-13

4. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma;World Journal of Gastroenterology;2023-01-14

5. Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway;Molecular Carcinogenesis;2022-12-28